[Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
Wollenhaupt
J
J
Abteilung Rheumatologie, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover. wollenhaupt.juergen@mh-hannover.de
Zeidler
H
H
D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D050607:Organogold Compounds; D010396:Penicillamine / Q000008:administration & dosage; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012460:Sulfasalazine / Q000008:administration & dosage
D018501:Antirheumatic Agents; D003524:Cyclosporins; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D050607:Organogold Compounds; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate